Unbranded advertising of prescription medicines to the public by pharmaceutical companies
Publication date
2017-07-10
Authors
Meneses Leonardo Alves, T.I.
Mantel-Teeuwisse, Aukje K.
Paschke, Anne
Leufkens, H.G.M.
Puil, Lorri
Poplavska, Elita
Mintzes, Barbara
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
taverne
Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effects of unbranded advertising of prescription medicines, conducted by or on behalf of pharmaceutical companies, on consumers' attitudes, knowledge, behaviour, health services use, health outcomes and costs.
Keywords
Taverne, Pharmacology (medical)
Citation
Meneses Leonardo Alves, T, Mantel-Teeuwisse, A K, Paschke, A, Leufkens, H G M, Puil, L, Poplavska, E & Mintzes, B 2017, 'Unbranded advertising of prescription medicines to the public by pharmaceutical companies', Cochrane Database of Systematic Reviews, vol. 2017, no. 7, CD012699. https://doi.org/10.1002/14651858.CD012699